# Homeodomain protein PRRX1 anchors the Ku heterodimers at DNA double-strand breaks to promote nonhomologous end-joining

**Authors:** Yan Wang, Fuyuan Shen, Chen Zhao, Jiali Li, Wen Wang, Yamu Li, Jia Gan, Haojian Zhang, Xuefeng Chen, Qiang Chen, Fangyu Wang, Ying Liu, Yan Zhou

PMC · DOI: 10.1093/nar/gkaf200 · Nucleic Acids Research · 2025-03-20

## TL;DR

This study reveals how the protein PRRX1 helps repair DNA breaks by anchoring a key repair complex, improving our understanding of DNA repair and cancer treatment.

## Contribution

PRRX1 is identified as a novel mediator of DNA–PK activation through direct interaction and stabilization at DNA breaks.

## Key findings

- PRRX1 binds DNA and Ku70 to stabilize DNA–PK at DNA double-strand breaks.
- PRRX1 mutations or reduced expression lead to genomic instability and impaired DNA repair.
- Disrupting PRRX1 oligomerization reduces NHEJ efficiency and cell survival after irradiation.

## Abstract

The DNA-dependent protein kinase (DNA–PK) complex plays a critical role in nonhomologous end-joining (NHEJ), a template-independent pathway for repairing DNA double-strand breaks (DSBs). The association of Ku70/80 with DSB ends facilitates the assembly of the DNA–PK holoenzyme. However, key mechanisms underlying the attachment and stabilization of DNA–PK at broken DNA ends remain unclear. Here, we identify PRRX1, a homeodomain-containing protein, as a mediator of chromatin localization and subsequent activation of DNA–PK. PRRX1 oligomerizes to simultaneously bind to double-strand DNA and the SAP (SAF-A/B, Acinus, and PIAS) domain of Ku70, thereby enhancing Ku anchoring at DSBs and stabilizing DNA–PK for efficient NHEJ repair. Reduced expression or pathogenic mutations of PRRX1 are associated with genomic instability and impaired NHEJ repair. Furthermore, a peptide that disrupts PRRX1 oligomerization compromises NHEJ efficiency and reduces cell survival following irradiation. These findings provide new insights into the activation of the NHEJ machinery and offer potential strategies for optimizing cancer therapies.

Graphical Abstract

## Linked entities

- **Genes:** PRRX1 (paired related homeobox 1) [NCBI Gene 5396]
- **Proteins:** PRRX1 (paired related homeobox 1), XRCC6 (X-ray repair cross complementing 6), XRCC5 (X-ray repair cross complementing 5), PRKDC (protein kinase, DNA-activated, catalytic subunit)

## Full-text entities

- **Genes:** ACIN1 (apoptotic chromatin condensation inducer 1) [NCBI Gene 22985] {aka ACINUS, ACN, fSAP152}, SH2D1A (SH2 domain containing 1A) [NCBI Gene 4068] {aka DSHP, EBVS, IMD5, LYP, MTCP1, SAP}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, PRRX1 (paired related homeobox 1) [NCBI Gene 5396] {aka AGOTC, PHOX1, PMX1, PRX-1, PRX1}, XRCC6 (X-ray repair cross complementing 6) [NCBI Gene 2547] {aka CTC75, CTCBF, G22P1, KU70, ML8, TLAA}
- **Diseases:** cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11925728/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11925728/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC11925728/full.md

---
Source: https://tomesphere.com/paper/PMC11925728